Published :
Tables : 65
Figures : 50
Category : Healthcare
No. of Pages : 240
Report Code : HC-U3261
Antimicrobial Susceptibility Testing Market is predicted to value over USD 4.6 billion by 2028 end with a CAGR of over 5.4% during the forecast period 2022 to 2028. Antimicrobial susceptibility testing (AST) is a method for evaluating which antibiotics are effective against a certain pathogen or group of bacteria. When bacteria and fungi are unable to live in the presence of one or more antimicrobial medicines, they are considered sensitive. It's a method for figuring out which antibiotics are the most efficient against microorganisms in the lab. It's used to see which antimicrobials prevent bacteria, fungi, and other pathogens from multiplying and causing disease. After bacteria, fungi, and viruses have been identified in a culture of the specimen, susceptibility testing is performed. Antimicrobial susceptibility testing (AST) is used to examine the efficacy of various antibiotics on bacteria, as well as antifungal and antiviral species, and to see if bacteria have evolved resistance to specific medicines. The findings of antimicrobial susceptibility testing test can be used to help choose the drug(s) that are most likely to be beneficial in treating a disease. Antibiotics are available to them. Regular antimicrobial susceptibility testing is performed to ensure that antibiotics are utilised effectively. It determines the lowest concentrations of new or existing antimicrobial medicines that prohibit consistent and detectable growth of the bacterium under research in certain test circumstances. It entails finding drug resistance in some of the most common diseases as well as determining the susceptibility of preferred treatments for certain infections. Furthermore, increased use of antimicrobial susceptibility testing by biopharmaceutical, biotechnological, and pharmaceutical companies, as well as overuse and misuse of antibiotics leading to antimicrobial resistance (AMR), is a major factor driving the antimicrobial susceptibility testing market's significant growth. Antimicrobial susceptibility testing of significant bacterial isolates is an important function of the clinical microbiology laboratory. During testing, the purpose is to detect possible drug resistance in common pathogens and to ensure susceptibility to drugs of choice for particular infections. The most widely used testing method is broth microdilution or rapid automated instrument methods that use commercially available materials and devices. Methods including disk diffusion and gradient diffusion can provide flexibility and possibly reduce costs. There are advantages and disadvantages to every method, including organisms that might be accurately tested. All methods provide some qualitative assessment (e.g., minimum inhibitory concentration), but some provide quantitative information (e.g., minimum inhibitory concentration). Antimicrobial resistance mechanisms are generally found to be accurately detected by current testing methods. FutureWise Market Research has instantiated a report that provides an intricate analysis of Antimicrobial Susceptibility Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Antimicrobial Susceptibility Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Antimicrobial Susceptibility Testing Market: • BioMérieux • BD • Danaher • Thermo Fisher • Bio-Rad Laboratories • Hi-Media • Merlin • Liofilchem • Accelerate • Alifax • Creative Diagnostics • Merck Group • Synbiosis • Bioanalyse • Zhuhai DL Biotech. (Note: The list of the major players will be updated with the latest market scenario and trends) Antimicrobial Susceptibility Testing Market Segmentation: By Product • Automated Laboratory Instruments • Manual Antimicrobial Susceptibility Testing Products o Susceptibility Testing Disks o MIC Strips o Susceptibility Plates • Culture and Growth Media • Consumables By Method • Dilution • Disk Diffusion • ETEST • Automated Antimicrobial Susceptibility Testing • Genotypic Methods By Type • Antibacterial Testing • Antifungal Testing • Antiparasitic Testing • Other Susceptibility Testing By Application • Clinical Diagnostics • Drug Discovery and Development • Epidemiology • Other Applications By End User • Diagnostic Centers and Hospitals • Pharmaceutical and Biotechnology Companies • Contract Research Organizations (CROs) • Research and Academic Institutes By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Antimicrobial Susceptibility Testing Market Sample Video: FutureWise Key Takeaways: Growth prospects SWOT analysis Key market trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global antimicrobial susceptibility testing market by product, by method, by type, by application, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Antimicrobial susceptibility testing (AST) is a method for evaluating which antibiotics are effective against a certain pathogen or group of bacteria. When bacteria and fungi are unable to live in the presence of one or more antimicrobial medicines, they are considered sensitive. It's a method for figuring out which antibiotics are the most efficient against microorganisms in the lab. It's used to see which antimicrobials prevent bacteria, fungi, and other pathogens from multiplying and causing disease. After bacteria, fungi, and viruses have been identified in a culture of the specimen, susceptibility testing is performed. Antimicrobial susceptibility testing (AST) is used to examine the efficacy of various antibiotics on bacteria, as well as antifungal and antiviral species, and to see if bacteria have evolved resistance to specific medicines. The findings of antimicrobial susceptibility testing test can be used to help choose the drug(s) that are most likely to be beneficial in treating a disease. Antibiotics are available to them. Regular antimicrobial susceptibility testing is performed to ensure that antibiotics are utilised effectively. It determines the lowest concentrations of new or existing antimicrobial medicines that prohibit consistent and detectable growth of the bacterium under research in certain test circumstances. It entails finding drug resistance in some of the most common diseases as well as determining the susceptibility of preferred treatments for certain infections. Furthermore, increased use of antimicrobial susceptibility testing by biopharmaceutical, biotechnological, and pharmaceutical companies, as well as overuse and misuse of antibiotics leading to antimicrobial resistance (AMR), is a major factor driving the antimicrobial susceptibility testing market's significant growth.
Antimicrobial susceptibility testing of significant bacterial isolates is an important function of the clinical microbiology laboratory. During testing, the purpose is to detect possible drug resistance in common pathogens and to ensure susceptibility to drugs of choice for particular infections. The most widely used testing method is broth microdilution or rapid automated instrument methods that use commercially available materials and devices. Methods including disk diffusion and gradient diffusion can provide flexibility and possibly reduce costs. There are advantages and disadvantages to every method, including organisms that might be accurately tested. All methods provide some qualitative assessment (e.g., minimum inhibitory concentration), but some provide quantitative information (e.g., minimum inhibitory concentration). Antimicrobial resistance mechanisms are generally found to be accurately detected by current testing methods.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Antimicrobial Susceptibility Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Antimicrobial Susceptibility Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Antimicrobial Susceptibility Testing Market:
• BioMérieux • BD • Danaher • Thermo Fisher • Bio-Rad Laboratories • Hi-Media • Merlin • Liofilchem • Accelerate • Alifax • Creative Diagnostics • Merck Group • Synbiosis • Bioanalyse • Zhuhai DL Biotech. (Note: The list of the major players will be updated with the latest market scenario and trends)
Antimicrobial Susceptibility Testing Market Segmentation: By Product • Automated Laboratory Instruments • Manual Antimicrobial Susceptibility Testing Products o Susceptibility Testing Disks o MIC Strips o Susceptibility Plates • Culture and Growth Media • Consumables By Method • Dilution • Disk Diffusion • ETEST • Automated Antimicrobial Susceptibility Testing • Genotypic Methods By Type • Antibacterial Testing • Antifungal Testing • Antiparasitic Testing • Other Susceptibility Testing By Application • Clinical Diagnostics • Drug Discovery and Development • Epidemiology • Other Applications By End User • Diagnostic Centers and Hospitals • Pharmaceutical and Biotechnology Companies • Contract Research Organizations (CROs) • Research and Academic Institutes By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Antimicrobial Susceptibility Testing Market Sample Video:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Antimicrobial Susceptibility Testing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Antimicrobial Susceptibility Testing Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Antimicrobial Susceptibility Testing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Antimicrobial Susceptibility Testing Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Automated Laboratory Instruments 7.2. Manual Antimicrobial Susceptibility Testing Products 7.2.1. Susceptibility Testing Disks 7.2.2. MIC Strips 7.2.3. Susceptibility Plates 7.3. Culture and Growth Media 7.4. Consumables 8. Antimicrobial Susceptibility Testing Market, By Method Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Dilution 8.2. Disk Diffusion 8.3. ETEST 8.4. Automated Antimicrobial Susceptibility Testing 8.5. Genotypic Methods 9. Antimicrobial Susceptibility Testing Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Antibacterial Testing 9.2. Antifungal Testing 9.3. Antiparasitic Testing 9.4. Other Susceptibility Testing 10. Antimicrobial Susceptibility Testing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Clinical Diagnostics 10.2. Drug Discovery and Development 10.3. Epidemiology 10.4. Other Applications 11. Antimicrobial Susceptibility Testing Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Diagnostic Centers and Hospitals 11.2. Pharmaceutical and Biotechnology Companies 11.3. Contract Research Organizations (CROs) 11.4. Research and Academic Institutes 12. North America Antimicrobial Susceptibility Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028 13. Latin America Antimicrobial Susceptibility Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028 14. Europe Antimicrobial Susceptibility Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028 15. Asia Pacific Antimicrobial Susceptibility Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. bioMérieux 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. BD 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Danaher 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Thermo Fisher 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Bio-Rad Laboratories 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Hi-Media 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. MERLIN 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Liofilchem 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Accelerate 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Alifax 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.Creative Diagnostics 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12.Merck Group 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13.Synbiosis 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14.Bioanalyse 18.14.1. Company Overview 18.14.2. Product Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15.Zhuhai DL Biotech 18.15.1. Company Overview 18.15.2. Product Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Antimicrobial Susceptibility Testing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Antimicrobial Susceptibility Testing Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Antimicrobial Susceptibility Testing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Antimicrobial Susceptibility Testing Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Automated Laboratory Instruments 7.2. Manual Antimicrobial Susceptibility Testing Products 7.2.1. Susceptibility Testing Disks 7.2.2. MIC Strips 7.2.3. Susceptibility Plates 7.3. Culture and Growth Media 7.4. Consumables
8. Antimicrobial Susceptibility Testing Market, By Method Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Dilution 8.2. Disk Diffusion 8.3. ETEST 8.4. Automated Antimicrobial Susceptibility Testing 8.5. Genotypic Methods
9. Antimicrobial Susceptibility Testing Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Antibacterial Testing 9.2. Antifungal Testing 9.3. Antiparasitic Testing 9.4. Other Susceptibility Testing
10. Antimicrobial Susceptibility Testing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Clinical Diagnostics 10.2. Drug Discovery and Development 10.3. Epidemiology 10.4. Other Applications
11. Antimicrobial Susceptibility Testing Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Diagnostic Centers and Hospitals 11.2. Pharmaceutical and Biotechnology Companies 11.3. Contract Research Organizations (CROs) 11.4. Research and Academic Institutes
12. North America Antimicrobial Susceptibility Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028
13. Latin America Antimicrobial Susceptibility Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028
14. Europe Antimicrobial Susceptibility Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028
15. Asia Pacific Antimicrobial Susceptibility Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028
17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. bioMérieux 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. BD 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Danaher 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Thermo Fisher 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Bio-Rad Laboratories 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Hi-Media 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. MERLIN 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Liofilchem 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Accelerate 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Alifax 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.Creative Diagnostics 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12.Merck Group 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13.Synbiosis 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14.Bioanalyse 18.14.1. Company Overview 18.14.2. Product Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15.Zhuhai DL Biotech 18.15.1. Company Overview 18.15.2. Product Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview
19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations
20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics